Cellares - The First Integrated Development and Manufacturing ...
WEBSep 5, 2024 · Unlock the Full Potential of Your Cell Therapy. Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century.
Cellares Stock Price, Funding, Valuation, Revenue & Financial …
WEBAug 23, 2023 · See Cellares funding rounds, investors, investments, exits and more. Evaluate their financials based on Cellares's post-money valuation and revenue.
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy ...
WEBMay 5, 2021 · SOUTH SAN FRANCISCO, Calif., May 5, 2021 /PRNewswire/ -- Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82...
Cellares Raises $255M Series C to Launch First Integrated …
WEBAug 23, 2023 · Cellares will use the new funding to launch the world's first commercial-scale IDMO Smart Factory, which seamlessly integrates advanced robotics, purpose-built technology, and interconnected ...
Bristol Myers Squibb and Cellares Announce a $380M Worldwide …
WEBApr 22, 2024 · BMY. Bristol Myers Squibb will utilize Cellares’ proprietary Cell Shuttle, a next-generation end-to-end, fully automated cell therapy manufacturing platform, for the clinical and commercial-scale...
Cellares Raises $255M Series C to Launch First Integrated …
WEBSOUTH SAN FRANCISCO, August 23, 2023 – Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies.
Bristol Myers Squibb and Cellares Announce a $380M Worldwide …
WEBApr 22, 2024 · PRINCETON, N.J. & SOUTH SAN FRANCISCO, Calif., April 22, 2024--Bristol Myers Squibb (NYSE: BMY) and Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to...
Bristol Myers Signs $380 Million CAR-T Therapies Supply Deal With Cellares
WEBApr 22, 2024 · (Reuters) -Drugmaker Bristol Myers Squibb said it has signed a $380 million deal with contract manufacturer Cellares to manufacture its CAR-T cell therapies in the United States, EU and Japan....
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy ...
WEBSOUTH SAN FRANCISCO, May 5th, 2021 – Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million.
Startup Cellares adds $255M as investors pour cash into cell …
WEBAug 24, 2023 · Cellares, a biotechnology startup that bills itself as the first “integrated” development and manufacturing organization dedicated to cell therapy, raised $255 million in a Series C financing.
Skip to content